Making clinical proteomics 100 times more robust and 10 times faster
Evosep Biosystems is a leading biotechnology research company dedicated to revolutionizing clinical proteomics. Evosep is committed to developing innovative solutions that enhance the robustness and speed of clinical proteomics, making it 100 times more robust and 10 times faster. With a focus on addressing the increasing demand for high-throughput, reliable solutions in clinical and large-scale proteomics, Evosep Biosystems is strategically positioned to bridge the gap between cutting-edge research and clinical applications.
Located at buchwaldsgade 35, 3rd floor, Odense C, Odense C 5000, DK, Evosep's foundation is built upon years of extensive experience in nano-UHPLC research and development, as well as application support. By critically re-evaluating the essential system architectures required for successful sample separation prior to mass spectrometric analysis, Evosep Biosystems ensures that its products meet the evolving needs of the proteomics community. Evosep is driving advancements in the field.
Evosep Biosystems aims to accelerate the integration of advanced proteomics into clinical practice. Evosep invites you to discover how its cutting-edge technologies and dedicated team are transforming clinical proteomics. We invite the company’s manager to create a customized and exclusive company showcase and product listing on our platform.
Evosep Biosystems er en førende bioteknologisk forskningsvirksomhed, der er dedikeret til at revolutionere klinisk proteomik. Evosep er engageret i at udvikle innovative løsninger, der forbedrer robustheden og hastigheden af klinisk proteomik, hvilket gør den 100 gange mere robust og 10 gange hurtigere. Med fokus på at imødekomme det stigende behov for højtydende, pålidelige løsninger inden for klinisk og storskala proteomik, er Evosep Biosystems strategisk positioneret til at bygge bro mellem banebrydende forskning og kliniske anvendelser.
Beliggende på Buchwaldsgade 35, 3. sal, Odense C, Odense C 5000, DK, er Evoseps fundament bygget på mange års omfattende erfaring inden for nano-UHPLC forskning og udvikling samt applikationssupport. Ved kritisk at revurdere de væsentlige systemarkitekturer, der kræves for vellykket prøveseparation forud for massespektrometrisk analyse, sikrer Evosep Biosystems, at dets produkter opfylder de skiftende behov i proteomik-fællesskabet. Evosep driver fremskridt inden for området.
Evosep Biosystems sigter mod at fremskynde integrationen af avanceret proteomik i klinisk praksis. Evosep inviterer dig til at opdage, hvordan dets banebrydende teknologier og dedikerede team transformerer klinisk proteomik. Vi inviterer virksomhedens leder til at oprette en tilpasset og eksklusiv virksomhedsfremvisning og produktliste på vores platform.
Compare Evosep Biosystems with 1 companies in Biotechnology-Research
| Comparison Field |
Evosep BiosystemsMain Company |
InterVenn Bioscience...View Profile |
|---|---|---|
|
Founded Year
|
— | 2017 |
|
Company Size
|
— | 51-200 |
|
City
|
Odense C, Odense C | South San Francisco, California |
|
Country
|
Denmark | United States |
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Proteomics
Biotechnology
Clinical Proteomics
Mass Spectrometry
LC-MS
UHPLC
Biotechnology Research
clinicalproteomics
proteomics
|
5 Total
5 Unique
Unique Skills:
artificial intelligence
biotech
epiproteomics
glycoproteomics
mass spectrometry
|
Other organizations in the same industry
This company is also known as